Michael John Dawson

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignees: Novacta Biosystems Limited, Cantab Anti-Infectives Limited. Active years: 2009-2016.

USPTO Granted Patents = 7

% Patents Active = 28.6

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 14(Granted Patents)

Location History:

Hatfield, GB (2009)
Welwyn Garden City, GB (2013 - 2015)
Hertfordshire, GB (2011 - 2016)

Company Filing History:

7 out of 12

Novacta Biosystems Limited

patents

1 out of 1

Cantab Anti-Infectives Limited

patent

where one patent can have more than one assignee

Years Active: 2009-2016

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9234006 - Compounds (2016-01-12),

2. 9006392 - Actagardine derivatives, and pharmaceutical use thereof (2015-04-14),

3. RE45003 - Lantibiotic biosynthetic gene clusters fromand (2014-07-07),

4. 8575094 - Use of type-B lantibiotic-based compounds having antimicrobial activity (2013-11-05),

5. 8465947 - [object Object] (2013-06-18),

6. 7989416 - [object Object] (2011-08-02),

7. 7592308 - F3W variants of the lantibiotic mersacidin and its use (2009-09-22),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]

4 patents pending (EPO):

Please report any incorrect information to [email protected]